Your browser doesn't support javascript.
loading
Serum miR-130b level, an ideal marker for monitoring the recurrence and prognosis of primary hepatocellular carcinoma after radiofrequency ablation treatment.
Hu, Xiang-Yu; Li, Li; Wu, Hong-Tao; Liu, Ying; Wang, Bei-Da; Tang, Ying.
Afiliação
  • Hu XY; Department of Ultrasound, Tianjin First Center Hospital, 300300, Tianjin, China.
  • Li L; Department of Ultrasound, Tianjin First Center Hospital, 300300, Tianjin, China.
  • Wu HT; Department of Ultrasound, Tianjin First Center Hospital, 300300, Tianjin, China.
  • Liu Y; Department of Ultrasound, Tianjin First Center Hospital, 300300, Tianjin, China.
  • Wang BD; Department of Ultrasound, Tianjin Dongli Hospital, 300192, Tianjin, China.
  • Tang Y; Department of Ultrasound, Tianjin First Center Hospital, 300300, Tianjin, China. Electronic address: drtang2002@aliyun.com.
Pathol Res Pract ; 214(10): 1655-1660, 2018 Oct.
Article em En | MEDLINE | ID: mdl-30153957

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Biomarcadores Tumorais / Carcinoma Hepatocelular / MicroRNAs / Neoplasias Hepáticas Tipo de estudo: Prognostic_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Biomarcadores Tumorais / Carcinoma Hepatocelular / MicroRNAs / Neoplasias Hepáticas Tipo de estudo: Prognostic_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2018 Tipo de documento: Article